ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3— 510(k) K030102
Substantially EquivalentBayer Healthcare, LLC
FDA 510(k) clearance K030102 for ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3, Substantially Equivalent on 2003-01-24. Applicant: Bayer Healthcare, LLC. Device class: 1.
Clearance details
- Applicant
- Bayer Healthcare, LLC
- Product code
- Code JJT
- Device class
- Class 1
- Regulation
- 21 CFR 862.1660
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Abbreviated
- Location
- Tarrytown, NY, US
Recent devices under product code JJT
view all- K090940 — SPOTCHECK BLOOD SPOT CONTROL, ASSAYED
- K062751 — MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER
- K030768 — CLINIQA LIQUID QC CARDIAC MARKER CONTROL LEVELS 1, 2 & 3, TRI-LEVEL
- K021498 — LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1, 2, 3, AND TRILEVEL
- K012656 — LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1,2,3, MODELS 646,647,648
More clearances from Bayer Healthcare, LLC
view all- K171802 — ALEVE Direct Therapy (ALEVE Direct Therapy TENS Device)
- K152852 — ALEVE Direct Therapy (ALEVE Direct Therapy TENS device)
- K130265 — CONTOUR NEXT EZ BLOOD GLUCOSE METER
- K121190 — CONTOUR NEXT BLOOD GLUCOSE METER
- K110587 — CONTOUR LINK BLOOD GLUCOSE METER, CONTOUR BLOOD GLUCOSE TEST STRIPS, CONTOUR CONTROL SOLUTION (HIGH, NORMAL, LOW)
Data sourced from openFDA. This site is unofficial and independent of the FDA.